Calcitriol-mediated hypercalcemia: Causes and course in 101 patients

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 10, 2013, Pages 4023-4029

  Donovan, Peter J ^a,d   Sundac, Lana ^a   Pretorius, Carel J ^a,b   D'Emden, Michael C ^d   McLeod, Donald S A ^a,c  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b Queensland Institute of Medical Research ^*  (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD LEVEL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CYSTADENOCARCINOMA; DELIRIUM; DEMOGRAPHY; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERCALCEMIA; INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; TONGUE CARCINOMA; VITAMIN BLOOD LEVEL;

ADULT; AGED; CALCITRIOL; FEMALE; HUMANS; HYPERCALCEMIA; MALE; MIDDLE AGED; NEOPLASMS; PARATHYROID HORMONE; PEPTIDYL-DIPEPTIDASE A; RETROSPECTIVE STUDIES; SARCOIDOSIS;

EID: 84885192437     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2016     Document Type: Article

References (30)

1. Jacobs TP, Bilezikian JP. Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab. 2005; 90: 6316-6322.
2. Kallas M, Green F, Hewison M., White C, Kline G. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab. 2010; 95: 3111-3117.
3. Baughman RP, Teirstein AS, Judson M.A., et al Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001; 164: 1885-1889.
4. Thomas KW, Hunninghake GW Sarcoidosis. JAMA. 2003; 289: 3300-3303.
5. Bell NH, Shary J, Shaw S., Turner RT Hypercalcemia associated with increased circulating 1, 25 dihydroxyvitamin D in a patient with pulmonary tuberculosis. Calcif Tissue Int. 1985; 37: 588-591.
6. Gkonos PJ, London R, Hendler ED Hypercalcemia and elevated 1, 25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med. 1984; 311: 1683-1685.
7. Seymour JF, Gagel RF Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood. 1993; 82: 1383-1394.
8. Adams JS, Fernandez M, Gacad M.A., et al Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood. 1989; 73: 235-239.
9. Seymour JF, Gagel RF, Hagemeister F.B., Dimopoulos MA, Cabanillas F. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Int Med. 1994; 121: 633-640.
10. Liang KV, Ryu JH, Matteson EL Histoplasmosis with tenosynovitis of the hand and hypercalcemia mimicking sarcoidosis. J Clin Rheumatol. 2004; 10: 138-142.
11. Playford EG, Bansal AS, Looke D.F., Whitby M., Hogan PG Hypercalcaemia and elevated 1, 25(OH)(2)D(3) levels associated with disseminated Mycobacterium avium infection in AIDS. J Infect. 2001; 42: 157-158.
12. Adams JS, Gacad MA Characterization of 1 α-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med. 1985; 161: 755-765.
13. Inui N, Murayama A, Sasaki S., et al Correlation between 25-hydroxyvitamin D3 1 α-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis. AmJMed. 2001; 110: 687-693.
14. Cadranel JL, Garabedian M, Milleron B., et al Vitamin D metabolism by alveolar immune cells in tuberculosis: correlation with calcium metabolism and clinical manifestations. Eur Respir J. 1994; 7: 1103-1110.
15. Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med. 2000; 6: 442-447.
16. Dusso AS, Kamimura S, Gallieni M., et al 7-Interferon-induced resistance to 1, 25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab. 1997; 82: 2222-2232.
17. Hewison M, Kantorovich V, Liker H.R., et al Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res. 2003; 18: 579-582.
18. Evans KN, Taylor H, Zehnder D., et al Increased expression of 25-hydroxyvitamin D-1α-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy. Am J Pathol. 2004; 165: 807-813.
19. Helikson MA, Havey AD, Zerwekh J.E., Breslau NA, Gardner DW Plasma-cell granuloma producing calcitriol and hypercalcemia. Ann Intern Med. 1986; 105: 379-381.
20. Mudde AH, van den Berg H, Boshuis PG, et al. Ectopic production of 1, 25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia. Cancer. 1987; 59: 1543-1546.
21. Australian Institute of Health and Welfare. Australia's Health 2012. Australia's health number 13. Cat. no. AUS 156. Canberra, Australia: AIHW.
22. Meikle AW, Tyler FH Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977; 63: 200-207.
23. Savvari P, Peitsidis P, Alevizaki M., Dimopoulos MA, Antsaklis A, Papadimitriou CA Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review. Onkologie. 2009; 32: 517-523.
24. Gavrila A, Hasinski S, Rose LI Hypercalcemia associated with squamous cell carcinoma of tongue. Endocr Pract. 2001; 7: 459-462.
25. Mundy GR, Edwards JR PTH-related peptide (PTHrP) in hypercalcemia. J Am Soc Nephrol. 2008; 19: 672-675.
26. da Silva M.A., Edmondson JW, Eby C, Loehrer PJ Sr. Humoral hypercalcemia in seminomas. Med Pediatr Oncol. 1992; 20: 38-41.
27. Grote TH, Hainsworth JD Hypercalcemia and elevated serum calcitriol in a patient with seminoma. Arch Intern Med. 1987; 147: 2212-2213.
28. Schutt AC, Bullington WM, Judson MA Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir Med. 2010; 104: 717-723.
29. Adams JS, Singer FR, Gacad M.A., et al Isolation and structural identification of 1, 25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab. 1985; 60: 960-966.
30. Bonnema SJ, Moller J, Marving J., Kvetny J. Sarcoidosis causes abnormal seasonal variation in 1, 25-dihydroxy-cholecalciferol. J Intern Med. 1996; 239: 393-398.